Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Onderzoek naar relatie COVID-19 en longembolie van start
apr 2020 | Benigne hematologie, Virale infecties